Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/23485
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports |
| Author: | Lim, S. Gillis, D. Smith, W. Hissaria, P. Greville, H. Peh, C. |
| Citation: | Internal Medicine Journal, 2006; 36(4):260-262 |
| Publisher: | Blackwell Publishing Asia |
| Issue Date: | 2006 |
| ISSN: | 1444-0903 1445-5994 |
| Statement of Responsibility: | S.W. Lim, D. Gillis, W. Smith, P. Hissaria, H. Greville and C.A. Peh |
| Abstract: | Rituximab is a chimeric monoclonal antibody specific for human CD20 that causes selective transient depletion of the CD20+ B-cell subpopulation. We report the first case of systemic lupus erythematosus (SLE) pneumonitis resistant to conventional treatments that responded well to rituximab and review current reports on the use of rituximab in SLE. |
| Keywords: | rituximab systemic lupus erythematosus pneumonitis B-cell depletion systemic autoimmune disease |
| DOI: | 10.1111/j.1445-5994.2006.01055.x |
| Published version: | http://www3.interscience.wiley.com/journal/118576212/abstract |
| Appears in Collections: | Aurora harvest 2 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.